Detalles de la búsqueda
1.
Packaging and Prefusion Stabilization Separately and Additively Increase the Quantity and Quality of Respiratory Syncytial Virus (RSV)-Neutralizing Antibodies Induced by an RSV Fusion Protein Expressed by a Parainfluenza Virus Vector.
J Virol
; 90(21): 10022-10038, 2016 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27581977
2.
The aberrant gene-end transcription signal of the matrix M gene of human parainfluenza virus type 3 downregulates fusion F protein expression and the F-specific antibody response in vivo.
J Virol
; 89(6): 3318-31, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25589643
3.
Enhanced Neutralizing Antibody Response Induced by Respiratory Syncytial Virus Prefusion F Protein Expressed by a Vaccine Candidate.
J Virol
; 89(18): 9499-510, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26157122
4.
Chimeric bovine/human parainfluenza virus type 3 expressing respiratory syncytial virus (RSV) F glycoprotein: effect of insert position on expression, replication, immunogenicity, stability, and protection against RSV infection.
J Virol
; 88(8): 4237-50, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24478424
5.
Evaluation of a Live-Attenuated Human Parainfluenza Virus Type 2 Vaccine in Adults and Children.
J Pediatric Infect Dis Soc
; 12(3): 173-176, 2023 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36594442
6.
Identification of human parainfluenza virus type 2 (HPIV-2) V protein amino acid residues that reduce binding of V to MDA5 and attenuate HPIV-2 replication in nonhuman primates.
J Virol
; 85(8): 4007-19, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21289116
7.
Herpes simplex virus-1 induces expression of a novel MxA isoform that enhances viral replication.
Immunol Cell Biol
; 89(2): 173-82, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-20603636
8.
Evaluation of a Live-Attenuated Human Parainfluenza Type 1 Vaccine in Adults and Children.
J Pediatric Infect Dis Soc
; 4(4): e143-6, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26582883
9.
Anti-metastatics: an overview of drug candidates in current pipelines.
Curr Pharm Des
; 20(42): 6522-8, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25341929
10.
Safety and infectivity of two doses of live-attenuated recombinant cold-passaged human parainfluenza type 3 virus vaccine rHPIV3cp45 in HPIV3-seronegative young children.
Vaccine
; 31(48): 5706-12, 2013 Nov 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-24103895
11.
Pathogenesis of acute respiratory illness caused by human parainfluenza viruses.
Curr Opin Virol
; 2(3): 294-9, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22709516
12.
Human parainfluenza virus serotypes differ in their kinetics of replication and cytokine secretion in human tracheobronchial airway epithelium.
Virology
; 433(2): 320-8, 2012 Nov 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-22959894
13.
Progress in the development of human parainfluenza virus vaccines.
Expert Rev Respir Med
; 5(4): 515-26, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21859271
14.
Growth restriction of an experimental live attenuated human parainfluenza virus type 2 vaccine in human ciliated airway epithelium in vitro parallels attenuation in African green monkeys.
Vaccine
; 28(15): 2788-98, 2010 Mar 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-20139039
15.
Human parainfluenza virus type 2 V protein inhibits interferon production and signaling and is required for replication in non-human primates.
Virology
; 397(2): 285-98, 2010 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-19969320
16.
Recombinant human parainfluenza virus type 2 with mutations in V that permit cellular interferon signaling are not attenuated in non-human primates.
Virology
; 406(1): 65-79, 2010 Oct 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-20667570
17.
Recombinant human parainfluenza virus type 2 vaccine candidates containing a 3' genomic promoter mutation and L polymerase mutations are attenuated and protective in non-human primates.
Vaccine
; 25(34): 6409-22, 2007 Aug 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-17658669
18.
ORF66 protein kinase function is required for T-cell tropism of varicella-zoster virus in vivo.
J Virol
; 80(23): 11806-16, 2006 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-16971426
Resultados
1 -
18
de 18
1
Próxima >
>>